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UNLABELLED: Ninety-three health care workers (HCW) in the Tokombere sahelian
district volunteered to participate in a trial to investigate viral markers of hepatitis B,
C, and D and HB vaccination status. METHODS: . Sera were tested using the Vikia
HBsAg kit followed by CMIA for detection of HBsAg, anti-HBs, anti-HBc, and anti-
HCV. HBsAg-positive HCW were tested for HBV-DNA, anti-HDV, and, if positive for
anti-HDV, HDV-RNA.RESULTS: Analysis of anti-HBc positivity indicated that 91% of
HCW had been infected by HBV, regardless of vaccination history. Vikia HBsAg
results were confirmed by chemiluminescent microparticle immunoassay (CMIA) in
all HCW and were positive in 17 HCW with virus load >2000 IU/mL in 6 and HDV co-
infection in 6. Anti-HCV was found in 6 HCW. Among the 55 HCW that had not been
vaccinated, only 3 needed vaccination because of anti-HBc negativity. Among HCW
considered for HBV treatment, one patient presenting HBV/HDV co-infection was
excluded after diagnosis of hepatocarcinoma. CONCLUSION: Systematic HB
vaccination of new HCW appears unnecessary in this rural region of Africa. Anti-HBc
screening is cost-effective for identifying HCW requiring vaccination. Vikia HBsAg is
effective for point-of-care screening. We underline the need for universal early
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